Differential action of monohydroxylated polycyclic aromatic hydrocarbons with estrogen receptors α and β

Toxicological Sciences

Volumn 132, Issue 2, 2013, Pages 359-367

  Sievers, Chelsie K ^a   Shanle, Erin K ^a,b   Bradfield, Christopher A ^a,b   Xu, Wei ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Dimerization; Estrogen receptors; Ligand binding.; Monohydroxylated metabolites; Polycyclic aromatic hydrocarbons; Transcription

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HOMODIMER; HYDROXYBENZO[A]PYRENE; NAPHTHALENE; NAPHTHALENE DERIVATIVE; PHENANTHRENE; PHENANTHRENE DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON;

ARTICLE; BINDING ASSAY; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DIMERIZATION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYDROXYLATION; LIGAND BINDING; METABOLITE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; ENERGY TRANSFER; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HYDROXYLATION; POLYCYCLIC COMPOUNDS;

EID: 84875241982     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfs287     Document Type: Article

References (26)

1. Anzenbacher, P., and Anzenbacherová, E. (2001). Cytochromes P450 and metabolism of xenobiotics. Cell. Mol. Life Sci. 58, 737-74
2. Arcaro, K. F., O'Keefe, P. W., Yang, Y., Clayton, W., and Gierthy, J. F. (1999). Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells. Toxicology 133, 115-12
3. Baird, W. M., Hooven, L. A., and Mahadevan, B. (2005). Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ. Mol. Mutagen. 45, 106-11
4. Bauer, E., Guo, Z., Ueng, Y. F., Bell, L. C., Zeldin, D., and Guengerich, F. P. (1995). Oxidation of benzo[a]pyrene by recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol. 8, 136-14
5. Cassidy, A., Brown, J. E., Hawdon, A., Faughnan, M. S., King, L. J., Millward, J., Zimmer-Nechemias, L., Wolfe, B., and Setchell, K. D. (2006). Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J. Nutr. 136, 45-5
6. Charles, G. D., Bartels, M. J., Zacharewski, T. R., Gollapudi, B. B., Freshour, N. L., and Carney, E. W. (2000). Activity of benzo[a]pyrene and its hydroxylated metabolites in an estrogen receptor-alpha reporter gene assay. Toxicol. Sci. 55, 320-32
7. Cho, T. M., Rose, R. L., and Hodgson, E. (2006). In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes. Drug Metab. Dispos. 34, 176-18
8. Elovaara, E., Mikkola, J., Mäkelä, M., Paldanius, B., and Priha, E. (2006). Assessment of soil remediation workers' exposure to polycyclic aromatic hydrocarbons (PAH): Biomonitoring of naphthols, phenanthrols, and 1-hydroxypyrene in urine. Toxicol. Lett. 162, 158-16
9. Fertuck, K. C., Kumar, S., Sikka, H. C., Matthews, J. B., and Zacharewski, T. R. (2001a). Interaction of PAH-related compounds with the alpha and beta isoforms of the estrogen receptor. Toxicol. Lett. 121, 167-17
10. Fertuck, K. C., Matthews, J. B., and Zacharewski, T. R. (2001b). Hydroxylated benzo[a]pyrene metabolites are responsible for in vitro estrogen receptormediated gene expression induced by benzo[a]pyrene, but do not elicit uterotrophic effects in vivo. Toxicol. Sci. 59, 231-24
11. Hartman, J., Lindberg, K., Morani, A., Inzunza, J., Ström, A., and Gustafsson, J. A. (2006). Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res. 66, 11207-1121
12. Hayakawa, K., Onoda, Y., Tachikawa, C., Hosoi, S., Yoshida, M., Chung, S., Kizu, R., Toriba, A., Kameda, T., and Tang, N. (2007). Estrogenic/antiestrogenic activities of polycyclic aromatic hydrocarbons and their monohydroxylated derivatives by yeast two-hybrid assay. J. Health Sci. 53, 562-57
13. Kim, J. H., Stansbury, K. H., Walker, N. J., Trush, M. A., Strickland, P. T., and Sutter, T. R. (1998). Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis 19, 1847-185
14. Koterba, K. L., and Rowan, B. G. (2006). Measuring ligand-dependent and ligand-independent interactions between nuclear receptors and associated proteins using Bioluminescence Resonance Energy Transfer (BRET). Nucl. Recept. Signal. 4, e02
15. Paruthiyil, S., Parmar, H., Kerekatte, V., Cunha, G. R., Firestone, G. L., and Leitman, D. C. (2004). Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res. 64, 423-42
16. Pike, A. C., Brzozowski, A. M., Hubbard, R. E., Bonn, T., Thorsell, A. G., Engström, O., Ljunggren, J., Gustafsson, J. A., and Carlquist, M. (1999). Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J. 18, 4608-461
17. Powell, E., Huang, S. X., Xu, Y., Rajski, S. R., Wang, Y., Peters, N., Guo, S., Xu, H. E., Hoffmann, F. M., Shen, B., et al. (2010). Identification and characterization of a novel estrogenic ligand actinopolymorphol A. Biochem. Pharmacol. 80, 1221-122
18. Powell, E., and Xu, W. (2008). Intermolecular interactions identify ligand-selective activity of estrogen receptor alpha/beta dimers. Proc. Natl. Acad. Sci. U.S.A. 105, 19012-1901
19. Rossbach, B., Preuss, R., Letzel, S., Drexler, H., and Angerer, J. (2007). Biological monitoring of occupational exposure to polycyclic aromatic hydrocarbons (PAH) by determination of monohydroxylated metabolites of phenanthrene and pyrene in urine. Int. Arch. Occup. Environ. Health 81, 221-22
20. Santodonato, J. (1997). Review of the estrogenic and antiestrogenic activity of polycyclic aromatic hydrocarbons: Relationship to carcinogenicity. Chemosphere 34, 835-84
21. Secreto, F. J., Monroe, D. G., Dutta, S., Ingle, J. N., and Spelsberg, T. C. (2007). Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells. J. Cell. Biochem. 101, 1125-114
22. Shanle, E. K., Hawse, J. R., and Xu, W. (2011). Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands. Biochem. Pharmacol. 82, 1940-194
23. Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E., and Chambon, P. (1989). The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 59, 477-48
24. Treeck, O., Lattrich, C., Springwald, A., and Ortmann, O. (2010). Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells. Breast Cancer Res. Treat. 120, 557-56
25. Tremblay, A., Tremblay, G. B., Labrie, F., and Giguère, V. (1999). Ligandindependent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol. Cell 3, 513-51
26. Wiele, T. V. D., Vanhaecke, L., Boeckaert, C., Peru, K., Headley, J., Verstraete, W., and Siciliano, S. (2005). Human colon microbiota transform polycyclic aromatic hydrocarbons to estrogenic metabolites. Environ. Health Perspect. 113, 6-1